iPLB

National Institute on Drug Abuse (NIDA) · Phase 3 active Small molecule Quality 0/100

At a glance

Generic name	iPLB
Also known as	Placebo injections
Sponsor	National Institute on Drug Abuse (NIDA)
Modality	Small molecule
Phase	Phase 3

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder (PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

iPLB CI brief — competitive landscape report
iPLB updates RSS · CI watch RSS
National Institute on Drug Abuse (NIDA) portfolio CI